Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase I/II Study of Epertinib Plus Trastuzumab With or Without Chemotherapy in Patients With HER2-Positive Metastatic Breast CancerBreast Cancer Res 2019 Dec 31;22(1)1, IR Macpherson, P Spiliopoulou, S Rafii, M Saggese, RD Baird, J Garcia-Corbacho, A Italiano, J Bonneterre, M Campone, N Cresti, J Posner, Y Takeda, A Arimura, J Spicer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.